• USEF Network The @ASPCA Maclay starts at 8 a.m. ET tomorrow in the Dixon Oval @Devon1896! A MUST watch for equitation fans. 5/26/2016 10:14:53 PM
  • USEF Network Late night stream! Watch the Spectrum International Paso Fino Horse Show live now: https://t.co/lbApx6zhBX https://t.co/Myv450uWt8 5/26/2016 9:59:37 PM
  • Sassy Strides Photo. Junior jumpers are streaming soon on @USEFNetwork from Devon!! Let's go Gia, Brian, and Helen👏🏼💪🏼 Retweeted by USEFNetwork 5/26/2016 6:04:52 PM
  • USEF Network @TheBrokeRider @bale_me_out here: https://t.co/ao1Wkbjkrj 5/26/2016 4:22:49 PM
  • espnW On @WorldMSDay, the inspiring story of Paralympic dressage hopeful Mary Jordan. WATCH: https://t.co/K51YGi1VVB Retweeted by USEFNetwork 5/26/2016 3:54:14 PM
  • #AdultAmmyStrong Today's work day has been made bearable by the @Devon1896 live stream on @USEFNetwork. #adultammyproblems #IWorkToRide Retweeted by USEFNetwork 5/26/2016 3:53:49 PM
  • SplitRockJumpingTour We're working on the Livestream! Thank you all for your patience! https://t.co/2B4EM0Rzw4 Retweeted by USEFNetwork 5/26/2016 3:19:14 PM
  • USEF Network Daisy Farish wins group A of the Pessoa/USEF Hunter Seat Medal. Groups B & C next. USEF Talent Search live in Dixon. https://t.co/uMUkB1 5/26/2016 2:16:12 PM
  • StreamHorseTV Called back for workoff in #Medal at @Devon1986: Taylor St. Jacques, Samantha Cohen, Daisy Farish, Melissa Foster. Watch in Gold Ring! Retweeted by USEFNetwork 5/26/2016 2:00:25 PM
  • USEF Network Test: canter directly to fence 1, trot fence 6, canter fence 7, counter canter fence 8, canter fence 9, and return to your place in line! 5/26/2016 2:00:14 PM

News

Luitpold Pharmaceuticals, Inc. Provides Adequan® (polysulfated glycosaminoglycan) Supply Update

RELEASE: June 27, 2013
AUTHOR/ADMINISTRATOR: Luitpold Pharmaceuticals, Inc.

Shirley, NY– Luitpold Animal Health, a division of Luitpold Pharmaceuticals, Inc., manufacturers of Adequan® IM, Adequan® IA, and Adequan® Canine provide the following supplyinterruption update:

Luitpold’s NY facility has undergone significant renovations and upgrades to meet enhanced quality standards and address observations made by the U.S. Food and Drug Administration (FDA). These renovations required cessation of manufacturing and affected Luitpold’s ability to release product. This has resulted in shortages in the marketplace. Luitpold has worked in recent months to optimally allocate inventory and manage the limited remaining supply, which has now been depleted.

Luitpold remains committed to resuming its manufacture and release of Adequan® products. We understand how critically important the Adequan® brands are to the health and well-being of the animals receiving treatment. The company’s latest expectations for reestablishing Adequan® supply to themarket is estimated to be first quarter 2014 however, this hinges upon completion of a successfulinspection by the FDA.

The company has established a dedicated webpage on www.adequan.com where concerned parties can register to receive future communications and updates on this matter. You may also contact our Customer Service Department at 1-800-458-0163.

During this supply interruption, we strongly recommend Veterinarians work together with equine and canine owners and caregivers to evaluate and decide upon the safest and most effective alternative treatments.

Adequan® IM and IA are the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness in horses. Adequan® Canine is the only polysulfated glycosaminoglycan (PSGAG) approved by the FDA for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.

Contact
Allyn Mann, Director
Luitpold Animal Health
Cell Phone: 816-590-5032
Email: amann@adequan.com

News

Competitions